| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nuo Therapeutics, Inc. | CEO/CFO, Director | Common Stock | 1.95M | $2.92M | $1.50 | 28 Nov 2025 | Direct |
| Nuo Therapeutics, Inc. | CEO/CFO, Director | Option to purchase common stock | 0 | 09 Aug 2018 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AURX | Nuo Therapeutics, Inc. | 28 Nov 2025 | 1 | -$300K | 4 | CEO/CFO, Director | 03 Dec 2025, 18:13 |
| AURX | Nuo Therapeutics, Inc. | 01 Aug 2025 | 4 | $40K | 4 | CEO/CFO, Director | 04 Aug 2025, 09:09 |
| AURX | Nuo Therapeutics, Inc. | 09 Nov 2022 | 9 | -$244K | 4 | CEO/CFO, Director | 14 Nov 2022, 17:43 |
| AURX | Nuo Therapeutics, Inc. | 29 Apr 2022 | 1 | $10.5K | 4 | CEO/CFO, Director | 02 May 2022, 12:23 |
| AURX | Nuo Therapeutics, Inc. | 04 Mar 2022 | 2 | $0 | 4 | CEO/CFO, Director | 26 Apr 2022, 21:29 |
| AURX | Nuo Therapeutics, Inc. | 31 Dec 2021 | 6 | $228K | 5 | CEO/CFO, Director | 26 Apr 2022, 21:25 |
| AURX | Nuo Therapeutics, Inc. | 31 Dec 2020 | 6 | $173K | 5 | CEO/CFO, Director | 26 Apr 2022, 21:22 |
| AURX | Nuo Therapeutics, Inc. | 31 Dec 2019 | 2 | $0 | 5 | CEO/CFO, Director | 26 Apr 2022, 21:18 |